Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cognitive Behavioral Therapy in Prolonging the Antidepressant Effects of Intravenous Ketamine

NCT02289248 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT02289248
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02289248 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cognitive Behavioral Therapy in Prolonging the Antidepressant Effects of Intravenous Ketamine
Lead sponsor
Yale University
Phase
Phase 1
Overall status
Completed
Start date
February 28, 2015
Completion date
October 31, 2016
Enrollment
16 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

depression